The Therapeutic Goods Administration has approved the manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia.
The Australian manufacture of COVID-19 Vaccine AstraZeneca, established by
Read More
Diverse COVID-19 vaccine portfolio needed, says Australian Greens
The Australian Greens have called on the federal government to increase the production of COVID-19 vaccines.
The party recently welcomed the news that AstraZeneca has been approved by the Therapeutic Goods
Read More
Read More
AstraZeneca invests $200m in local manufacturing capability
Global biopharmaceuticals manufacturer AstraZeneca has committed $200 million to the company’s facility in North Ryde, Sydney.
The investment will go towards increasing the facility’s production capabilities,
Read More
Read More
Growth in manufacturing operations: The best kind of problem to have
While conditions in the Australian manufacturing industry remain challenging amid weakness in the global economy, there are certain companies that are bucking the trend and taking advantage of strong opportunities for growth.
Read More
Read More
Advanced Australian manufacturers: AstraZeneca’s $80 million investment
Australia’s car industry is faltering and our wine sector is facing increasing offshore competition, however, there is good news when it comes to pharmaceutical manufacturers, Alex Heber reports.
Read More
Read More